Rapidly Progressing Fatal Neurobrucellosis in a Healthy Child in an Endemic Area in Southern Israel

Isr Med Assoc J. 2017 Feb;19(2):125-127.

Authors

Avishay Tzur¹, Yair Sedaka¹, Yariv Fruchtman², Eugene Leibovitz², Yuval Cavari³, Iris Noyman¹, Shalom Ben-Shimol⁴, Ilan Shelef⁵, Isaac Lazar³

Affiliations

¹ Pediatric Neurology Unit, Soroka University Medical Center and Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva, Israel.
² Pediatric Emergency Medicine Unit, Soroka University Medical Center and Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva, Israel.
³ Pediatric Intensive Care Unit, Soroka University Medical Center and Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva, Israel.
⁴ Pediatric Infectious Disease, Soroka University Medical Center and Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva, Israel.
⁵ Department of Radiology, Soroka University Medical Center and Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva, Israel.

PMID: 28457067

No abstract available

Publication types

Case Reports

MeSH terms

Anti-Bacterial Agents / administration & dosage*
Anticonvulsants / administration & dosage
Arabs
Brain / diagnostic imaging
Brain Diseases* / diagnosis
Brain Diseases* / microbiology
Brain Diseases* / physiopathology
Brain Diseases* / therapy
Brucella / isolation & purification*
Brucellosis* / complications
Brucellosis* / diagnosis
Child
Computed Tomography Angiography / methods
Diagnosis, Differential
Electroencephalography / methods
Fatal Outcome
Glasgow Coma Scale
Humans
Israel
Male
Meningitis, Bacterial* / diagnosis
Meningitis, Bacterial* / microbiology
Meningitis, Bacterial* / physiopathology
Meningitis, Bacterial* / therapy
Neurologic Examination / methods
Respiration, Artificial / methods
Time-to-Treatment

Substances

Anti-Bacterial Agents
Anticonvulsants